Brcarib 150mg Tablet: Effective Relief for Your Health Needs

Brcarib 150mg Tablet

Class of medication: Cancer medications, PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors.

Active ingredient: Olaparib.

Uses:

• Maintenance therapy for various types of advanced ovarian cancer.
• Treatment of early and metastatic breast cancer.
• Treatment of prostate cancer.
• Metastatic pancreatic cancer.

Mechanism of action:

• Inhibits the enzyme poly (ADP-ribose) polymerase (PARP), which plays a role in repairing damaged DNA in cells.
• Prevents cancer cells from repairing their DNA, leading to cell death.

Important information:

• Do not take if you are allergic to the active compound and other ingredients of the medicine.
• Consult your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing.
• Blood tests will be conducted before and every month during treatment.
• Inform your healthcare provider about all the medicines you are taking, including prescription, over-the-counter drugs, vitamins, and supplements.
• Not advised to use while pregnant or breastfeeding.
• Keep out of reach of children.
• Store at room temperature (20°C to 25°C).

Dosage and administration:

• The medicine will be prescribed by a healthcare professional.
• Take with or without food, as directed by your healthcare provider.
• Swallow the tablet whole with a glass of water.
• Take at the same time every day.

Safety advice:

• Pregnancy: not recommended during pregnancy as it may harm the unborn baby.
• Breastfeeding: it is unknown whether Brcarib 150mg Tablet passes into breast milk. It is not recommended to nurse a child during and after 1 month of completion of therapy.
• Lungs: consult your doctor if you have any lung diseases before starting treatment.
• Liver: inform your physician if you have any liver problems before starting treatment.
• Alcohol: it is unknown whether consuming alcohol interacts with the Brcarib 150mg Tablet. Consult your doctor for more advice.
• Driving: Brcarib 150mg Tablet may have an impact on your ability to operate machinery and drive.

Side effects:

• Common: shortness of breath, nausea, vomiting, fatigue, dyspepsia, loss of appetite, dizziness, diarrhoea, headache.
• Serious: neutropenia, acute myeloid leukemia, leukopenia, thrombocytopenia, lung problems.

Word of advice:

• Brcarib 150mg Tablet can lower blood cell counts, so it's best to get blood tests done at regular intervals.
• Stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside.
• Do not stop taking Brcarib 150mg Tablet without first talking to your doctor.
• Avoid grapefruit juice as it may raise your blood levels of the drug.
• Maintain a sufficient fluid intake to prevent dehydration.

FAQs:

1. Can Brcarib 150mg Tablet be taken during pregnancy or breastfeeding? Brcarib 150mg Tablet may harm an unborn baby and should not be used during pregnancy. It is also not recommended while breastfeeding, as it may pass into breast milk and harm the nursing infant.

2. What are Brcarib 150mg Tablet's typical side effects? Nausea, vomiting, lethargy, diarrhoea, appetite loss, and blood cell count abnormalities are typical adverse effects.

3. Are there any dietary restrictions I need to follow while on Brcarib 150mg Tablet? There are no specific dietary restrictions associated with Brcarib 150mg Tablet. However, it's essential to maintain a healthy and balanced diet to support your overall well-being during treatment. It is recommended to avoid grape juice as it increases the blood drug concentration.

4. Is Brcarib 150mg Tablet used as a standalone treatment in cancers? Brcarib 150mg Tablet is usually indicated as maintenance therapy after a person completes a platinum-based chemotherapy regimen for ovarian cancer. However, newer studies are evaluating its solitary efficacy in treating different types of cancers.

5. Can I drive or operate machinery while taking Brcarib 150mg Tablet? Brcarib 150mg Tablet may cause side effects such as dizziness or fatigue, which could impair your ability to drive or operate machinery safely. If you're unsure, it's best to consult with your healthcare provider for personalized advice based on your specific situation.

Fact box:

• Molecule name: Olaparib.
• Therapeutic class: Antineoplastic agents.
• Pharmacological class: Poly Adenosine Diphosphate-Ribose Polymerase (PARP) inhibitor.

Tags: Brcarib, 150mg, Tablet, Health, Medicine, Pharmaceuticals